May 18, 2020 / 6:30 AM / 19 days ago

BRIEF-Astrazeneca Says Bevespi Aerosphere Approved In China For COPD

May 18 (Reuters) - AstraZeneca Plc:

* BEVESPI AEROSPHERE APPROVED IN CHINA FOR COPD

* BEVESPI AEROSPHERE APPROVED IN CHINA AS MAINTENANCE TREATMENT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

* APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION WAS BASED ON POSITIVE RESULTS FROM PHASE III PINNACLE 4 TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below